134 related articles for article (PubMed ID: 35048995)
1. Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice.
Jiang B; Shi Y; Abou MB; Xu L; Liang G; Wei H
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):198-203. PubMed ID: 35048995
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
Shi Y; Zhang L; Gao X; Zhang J; Ben Abou M; Liang G; Meng Q; Hepner A; Eckenhoff MF; Wei H
J Alzheimers Dis; 2020; 76(4):1375-1389. PubMed ID: 32623395
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
J Alzheimers Dis; 2024; 98(2):549-562. PubMed ID: 38393915
[TBL] [Abstract][Full Text] [Related]
4. Intranasal instillation of aflatoxin B(1) in rats: bioactivation in the nasal mucosa and neuronal transport to the olfactory bulb.
Larsson P; Tjälve H
Toxicol Sci; 2000 Jun; 55(2):383-91. PubMed ID: 10828271
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with Naegleria fowleri lysates and Cry1Ac induces metaplasia in the olfactory epithelium and increases IgA secretion.
Jarillo-Luna A; Moreno-Fierros L; Campos-Rodríguez R; Rodríguez-Monroy MA; Lara-Padilla E; Rojas-Hernández S
Parasite Immunol; 2008 Jan; 30(1):31-8. PubMed ID: 18086014
[TBL] [Abstract][Full Text] [Related]
6. Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Torika N; Asraf K; Cohen H; Fleisher-Berkovich S
Brain Behav Immun; 2017 Aug; 64():80-90. PubMed ID: 28385651
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of dantrolene increased brain concentration and duration.
Wang J; Shi Y; Yu S; Wang Y; Meng Q; Liang G; Eckenhoff MF; Wei H
PLoS One; 2020; 15(3):e0229156. PubMed ID: 32160210
[TBL] [Abstract][Full Text] [Related]
8. Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.
Peng J; Liang G; Inan S; Wu Z; Joseph DJ; Meng Q; Peng Y; Eckenhoff MF; Wei H
Neurosci Lett; 2012 May; 516(2):274-9. PubMed ID: 22516463
[TBL] [Abstract][Full Text] [Related]
9. Transfer of some carboxylic acids in the olfactory system following intranasal administration.
Eriksson C; Bergman U; Franzén A; Sjöblom M; Brittebo EB
J Drug Target; 1999; 7(2):131-42. PubMed ID: 10617298
[TBL] [Abstract][Full Text] [Related]
10. 3-Methylindole-induced nasal mucosal damage in mice.
Turk MA; Henk WG; Flory W
Vet Pathol; 1987 Sep; 24(5):400-3. PubMed ID: 3672805
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of 2,6-dichlorothiobenzamide (chlorthiamid) and 2,6-dichlorobenzamide in the olfactory nasal mucosa of mice.
Brittebo EB; Eriksson C; Feil V; Bakke J; Brandt I
Fundam Appl Toxicol; 1991 Jul; 17(1):92-102. PubMed ID: 1916084
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal administration.
Cui X; Cao DY; Wang ZM; Zheng AP
Pharmazie; 2013 Jan; 68(1):69-74. PubMed ID: 23444784
[TBL] [Abstract][Full Text] [Related]
13. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
[TBL] [Abstract][Full Text] [Related]
14. Moderate leukocyte infiltration in the lower turbinate mucosa after a two-week intranasal administration of mometasone furoate, azelastine or salmon calcitonin.
Vera-Cruz P; Ferreira M; Zagalo C; dos Santos MJ; Aguas AP
Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):105-9. PubMed ID: 19813472
[TBL] [Abstract][Full Text] [Related]
15. Morphology of nasal lesions induced in Osborne-Mendel rats and B6C3F1 mice by chronic inhalation of allyl glycidyl ether.
Renne RA; Brown HR; Jokinen MP
Toxicol Pathol; 1992; 20(3 Pt 1):416-25. PubMed ID: 1295070
[TBL] [Abstract][Full Text] [Related]
16. Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis.
Klossek JM; Laliberté F; Laliberté MF; Mounedji N; Bousquet J
Rhinology; 2001 Mar; 39(1):17-22. PubMed ID: 11340690
[TBL] [Abstract][Full Text] [Related]
17. Brain transit and ameliorative effects of intranasally delivered anti-amyloid-β oligomer antibody in 5XFAD mice.
Xiao C; Davis FJ; Chauhan BC; Viola KL; Lacor PN; Velasco PT; Klein WL; Chauhan NB
J Alzheimers Dis; 2013; 35(4):777-88. PubMed ID: 23542865
[TBL] [Abstract][Full Text] [Related]
18. Influence of intranasal medication on the structure of the nasal mucosa.
Wang J; Bu G
Chin Med J (Engl); 2002 Apr; 115(4):617-9. PubMed ID: 12133312
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
20. Effect of perchloroethylene inhalation on nasal mucosa in mice.
Aoki A; Suzaki H; Kawabata Y; Nomura Y
Eur Arch Otorhinolaryngol; 1994; 251(6):361-5. PubMed ID: 7848648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
